Cargando…
Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
Alcoholic liver disease (ALD) is linked to a broad spectrum of diseases, including diabetes, hypertension, atherosclerosis, and even liver carcinoma. The ALD spectrum includes alcoholic fatty liver disease (AFLD), alcoholic hepatitis, and cirrhosis. Most recently, some reports demonstrated that the...
Autores principales: | Oh, Ki-Kwang, Choi, Ye-Rin, Gupta, Haripriya, Ganesan, Raja, Sharma, Satya Priya, Won, Sung-Min, Jeong, Jin-Ju, Lee, Su-Been, Cha, Min-Gi, Kwon, Goo-Hyun, Kim, Dong-Joon, Suk, Ki-Tae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316215/ https://www.ncbi.nlm.nih.gov/pubmed/35877448 http://dx.doi.org/10.3390/cimb44070224 |
Ejemplares similares
-
Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023) -
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
por: Hyun, Ji Ye, et al.
Publicado: (2022) -
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023) -
The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023)